Synthetic Approaches to the New Drugs Approved During 2021

被引：13

作者：

McInturff, Emma L. ^{[1
]}

France, Scott P. ^{[2
]}

Leverett, Carolyn A. ^{[1
]}

Flick, Andrew C. ^{[3
]}

Lindsey, Erick A. ^{[3
]}

Berritt, Simon ^{[1
]}

Carney, Daniel W. ^{[3
]}

DeForest, Jacob C. ^{[4
]}

Ding, Hong X. ^{[5
]}

Fink, Sarah J. ^{[6
]}

Gibson, Tony S. ^{[3
]}

Gray, Kaitlyn ^{[1
]}

Hubbell, Aran K. ^{[1
]}

Johnson, Amber M. ^{[1
]}

Liu, Yiyang ^{[1
]}

Mahapatra, Subham ^{[1
]}

McAlpine, Indrawan J. ^{[7
]}

Watson, Rebecca B. ^{[4
]}

O'Donnell, Christopher J. ^{[1
]}

机构：

[1] Pfizer Worldwide Res & Dev, Groton Labs, Groton, CT 06340 USA

[2] Merck & Co Inc, Proc Res & Dev, Rahway, NJ 07065 USA

[3] Takeda Pharmaceut, San Diego, CA 92121 USA

[4] Pfizer Worldwide Res & Dev, La Jolla Labs, San Diego, CA 92121 USA

[5] Pharmacodia Beijing Co Ltd, Beijing 100085, Peoples R China

[6] Takeda Pharmaceut, Cambridge, MA 02142 USA

[7] Genesis Therapeut, San Diego, CA 92121 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 66卷 / 15期

关键词：

ATOPIC-DERMATITIS; MOLYBDENUM COFACTOR; PHOSPHODIESTERASE-4; INHIBITOR; BIOLOGICAL EVALUATION; RECEPTOR ANTAGONIST; DOUBLE-BLIND; POTENT; CANCER; HYDROCHLORIDE; MOLNUPIRAVIR;

D O I：

10.1021/acs.jmedchem.3c00501

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Each year, new drugs are introduced to the market, representingstructures that have affinity for biological targets implicated inhuman diseases and conditions. These new chemical entities (NCEs),particularly small molecules and antibody-drug conjugates,provide insight into molecular recognition and serve as potentialleads for the design of future medicines. This annual review is partof a continuing series highlighting the most likely process-scalesynthetic approaches to 35 NCEs that were first approved anywherein the world during 2021.

引用

页码：10150 / 10201

页数：52

共 50 条

[1] Synthetic Approaches to the New Drugs Approved During 2017
Flick, Andrew C.
Leverett, Carolyn A.
Ding, Hong X.
McInturff, Emma
Fink, Sarah J.
Helal, Christopher J.
O'Donnell, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (16) : 7340 - 7382
[2] Synthetic Approaches to New Drugs Approved During 2016
Flick, Andrew C.
Ding, Hong X.
Leverett, Carolyn A.
Fink, Sarah J.
O'Donnell, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (16) : 7004 - 7031
[3] Synthetic Approaches to the New Drugs Approved During 2022
France, Scott P.
Lindsey, Erick A.
McInturff, Emma L.
Berritt, Simon
Carney, Daniel W.
DeForest, Jacob C.
Fink, Sarah J.
Flick, Andrew C.
Gibson, Tony S.
Gray, Kaitlyn
Johnson, Amber M.
Leverett, Carolyn A.
Liu, Yiyang
Mahapatra, Subham
Watson, Rebecca B.
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4376 - 4418
[4] Synthetic Approaches to the New Drugs Approved during 2023
France, Scott P.
Lindsey, Erick A.
Mcinturff, Emma L.
Berritt, Simon
Deforest, Jacob
Flick, Andrew C.
Fink, Sarah
Gibson, Tony S.
Gray, Kaitlyn
Hubbell, Aran K.
Johnson, Amber M.
Liu, Yiyang
Mahapatra, Subham
Watson, Rebecca B.
Zhou, Zhiyao
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 2147 - 2182
[5] Synthetic Approaches to New Drugs Approved during 2018
Flick, Andrew C.
Leverett, Carolyn A.
Ding, Hong X.
McInturff, Emma
Fink, Sarah J.
Helal, Christopher J.
DeForest, Jacob C.
Morse, Peter D.
Mahapatra, Subham
O'Donnell, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 10652 - 10704
[6] Synthetic Approaches to the New Drugs Approved During 2020
Flick, Andrew C.
Leverett, Carolyn A.
Ding, Hong X.
McInturff, Emma L.
Fink, Sarah J.
Mahapatra, Subham
Carney, Daniel W.
Lindsey, Erick A.
DeForest, Jacob C.
France, Scott P.
Berritt, Simon
Bigi-Botterill, Simone, V
Gibson, Tony S.
Watson, Rebecca B.
Liu, Yiyang
O'Donnell, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 9607 - 9661
[7] Synthetic Approaches to the New Drugs Approved During 2015
Flick, Andrew C.
Ding, Hong X.
Leverett, Carolyn A.
Kyne, Robert E., Jr.
Liu, Kevin K. -C.
Fink, Sarah J.
O'Donnell, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (15) : 6480 - 6515
[8] Synthetic Approaches to the New Drugs Approved during 2019
Flick, Andrew C.
Leverett, Carolyn A.
Ding, Hong X.
McInturff, Emma
Fink, Sarah J.
Mahapatra, Subham
Carney, Daniel W.
Lindsey, Erick A.
DeForest, Jacob C.
France, Scott P.
Berritt, Simon
Bigi-Botterill, Simone, V
Gibson, Tony S.
Liu, Yiyang
O'Donnell, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (07) : 3604 - 3657
[9] New Drugs Approved in 2021
Ebied, Alex M.
Elmariah, Hesham
Cooper-DeHoff, Rhonda M.
AMERICAN JOURNAL OF MEDICINE, 2022, 135 (07): : 836 - 839
[10] Synthetic Approaches to the New Drugs Approved During 2015 (vol 60, pg 6480, 2017)
Flick, Andrew C.
Ding, Hong X.
Leverett, Carolyn A.
Kyne, Robert E., Jr.
Liu, Kevin K-C.
Fink, Sarah J.
O'Donnell, Christopher J.
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (20) : 8680 - 8680

← 1 2 3 4 5 →